Gene variation boosts heart disease risk from chemo

05/21/2010 | HealthDay News

Children with CBR gene variations who are given anthracycline chemotherapy for cancer have a higher risk of developing heart disease later in life, a study found. Researchers said the data could one day help doctors screen children for the variation and offer alternative therapies that don't damage the heart.

View Full Article in:

HealthDay News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC